5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 8.87▲ | 8.91▼ | 8.91▼ | 9.06▼ | 9.23▼ |
MA10 | 8.89▼ | 8.98▼ | 9.03▼ | 9.13▼ | 9.02▼ |
MA20 | 9.00▼ | 9.09▼ | 9.09▼ | 9.32▼ | 8.37▲ |
MA50 | 9.06▼ | 9.07▼ | 9.10▼ | 9.00▼ | 7.17▲ |
MA100 | 9.03▼ | 9.16▼ | 9.27▼ | 8.20▲ | 6.39▲ |
MA200 | 9.16▼ | 9.27▼ | 9.18▼ | 7.10▲ | 6.99▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.012▼ | -0.029▼ | -0.029▼ | -0.067▼ | 0.010▲ |
RSI | 37.890▼ | 36.269▼ | 38.810▼ | 44.434▼ | 63.122▲ |
STOCH | 18.902▼ | 10.442▼ | 6.161▼ | 41.916 | 68.218 |
WILL %R | -80.952▼ | -90.361▼ | -91.111▼ | -61.333 | -42.412 |
CCI | -64.747 | -102.703▼ | -114.234▼ | -90.932 | 40.861 |
Wednesday, April 24, 2024 11:26 AM
Results from Phase 2b ReNeu trial of mirdametinib in NF1-PN accepted for oral presentation –– Additional data from the Phase 3 DeFi trial of ...
|
Wednesday, April 24, 2024 05:00 AM
FUROSCIX Auto-injector being developed as a complement to the FUROSCIX On-body Infusor Company anticipates topline data in Q3 2024, followed by a Supplemental New Drug Application (sNDA) by year-end ...
|
Wednesday, April 24, 2024 05:00 AM
Serve Robotics Inc. (the "Company" or "Serve") (NASDAQ:SERV), a leading autonomous sidewalk delivery company, today announced an expansion of their existing agreement with Magna International Inc.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
24/04/24 | 9.15 | 9.1991 | 8.81 | 8.93 | 74,819 |
23/04/24 | 9.07 | 9.28 | 9.05 | 9.24 | 41,472 |
22/04/24 | 9.11 | 9.36 | 9.07 | 9.12 | 54,030 |
19/04/24 | 8.89 | 9.10 | 8.86 | 9.08 | 46,920 |
18/04/24 | 9.17 | 9.17 | 8.74 | 8.94 | 67,129 |
17/04/24 | 9.31 | 9.31 | 9.01 | 9.10 | 31,775 |
16/04/24 | 9.10 | 9.85 | 9.0067 | 9.31 | 102,038 |
15/04/24 | 9.00 | 9.31 | 8.85 | 9.19 | 92,392 |
12/04/24 | 9.21 | 9.24 | 8.93 | 9.05 | 35,251 |
11/04/24 | 9.10 | 9.39 | 9.00 | 9.34 | 55,240 |
|
|
||||
|
|
||||
|
|